Stay updated on Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA notice about NIH’s terminology transition appears above the site navigation, and the site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1 while the study page continues to display a 403 error.SummaryDifference0.2%

- Check33 days agoChange DetectedThe study page now renders a 403 Forbidden error with a minimal HTML frame and a Home link, indicating restricted access rather than updated study information.SummaryDifference0.5%

- Check40 days agoChange DetectedThe page now shows a 403 Forbidden error page instead of the study record content, with a Home link replacing the previous details. This indicates the page is currently inaccessible, rather than presenting any new study information.SummaryDifference19%

- Check47 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing Revision: v3.6.6, indicating an updated version of the study record display.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision was bumped from v3.6.5 to v3.6.6. This indicates a minor update to the page’s content or metadata without changing study information.SummaryDifference0.1%

Stay in the know with updates to Amivantamab in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab in Adenoid Cystic Carcinoma Clinical Trial page.